By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sangamo BioSciences, Inc. 

501 Canal Boulevard
Suite A100
Richmond  California  94804  U.S.A.
Phone: 510-970-6000 Fax: 510-236-8951


SEARCH JOBS


Key Statistics


Email: lanphier@sangamo.com
Ownership: Public

Web Site: Sangamo
Employees:
Symbol: SGMO
 



Industry
Biotechnology






Company News
Sangamo (SGMO) Reports Fourth Quarter And Full Year 2015 Financial Results 2/9/2016 12:11:47 PM
Sangamo (SGMO) Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I 2/8/2016 6:10:43 AM
Sangamo BioSciences (SGMO) Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference 2/5/2016 6:55:56 AM
Sangamo BioSciences (SGMO) Announces Fourth Quarter And Full Year 2015 Conference Call And Webcast 2/3/2016 6:44:02 AM
Sangamo BioSciences (SGMO) Highlights 2016 Catalysts At The 34th Annual J.P. Morgan Healthcare Conference 1/11/2016 11:23:12 AM
Sangamo BioSciences (SGMO) Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference 1/6/2016 10:33:30 AM
Sangamo BioSciences (SGMO) Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies 12/11/2015 6:21:36 AM
Sangamo BioSciences (SGMO) Presents Data At The 2015 American Society of Hematology Meeting Highlighting ZFP Therapeutic Programs For Hemophilia And Hemoglobinopathies 12/7/2015 9:36:14 AM
Sangamo BioSciences (SGMO) Presents Data At The 2015 American Society of Hematology Meeting Highlighting ZFP Therapeutic Programs For Hemophilia And Hemoglobinopathies 12/7/2015 7:51:52 AM
Sangamo BioSciences (SGMO) Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B 12/1/2015 6:25:11 AM
12345678910...
//-->